Shanghai Pioneer (HKG:1345) expects a decline of between 45% to 48% in net profit for the first half of 2025 from 87.9 million yuan a year prior, a Tuesday filing with the Hong Kong bourse said.
The pharmaceutical products producer attributed the forecast to a significant drop in government grants received in the period.